I have long been engaged in research on drug metabolism and the molecular mechanisms underlying metabolic diseases. My current research focuses on metabolic disorders and cancer associated with the gut and liver, with particular emphasis on metabolic regulation, disease mechanisms, and the gut–liver axis. In parallel, I am actively involved in the development of metabolism-related therapeutic agents. My work aims to elucidate the metabolic basis of disease progression and to facilitate the discovery of novel therapeutic targets and drug development strategies for metabolic diseases and cancer.